JO
UTRS

John Overdeck’s Minerva Surgical, Inc. Common Stock UTRS Stock Holding History

John Overdeck’s Portfolio UTRS Stock Details UTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,209
Closed -$227K – 4678
2021
Q4 		$227K Buy
+2,209
New +$314K ﹤0.01% 3838

Other funds holding UTRS

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LM
Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

John Overdeck's UTRS Position: Q1 2022 in Review

John Overdeck sold out of Minerva Surgical, Inc. Common Stock (UTRS) in Q1 2022, closing a stake of 2,209 shares — an estimated $227K sold.

John Overdeck first reported a position in UTRS in Q4 2021 and held it in 1 quarter. The position peaked at $227K in Q4 2021. 20 funds tracked by Wall St. Rank hold UTRS as of Q1 2022.

  • John Overdeck reported no remaining Minerva Surgical, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • John Overdeck sold 2,209 Minerva Surgical, Inc. Common Stock shares in Q1 2022, an estimated $227K.
  • John Overdeck first reported a position in Minerva Surgical, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • John Overdeck's Minerva Surgical, Inc. Common Stock position peaked at $227K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held Minerva Surgical, Inc. Common Stock as of Q1 2022.

Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.